Levine interviewed by Financial Times about Section 5 enforcement

Jay Levine, a partner in Porter Wright's antitrust practice, recently was interviewed for the article, "New FTC commissioner could expand Section 5 enforcement against branded drug makers," published in the Feb. 20, 2014 edition of the Policy and Regulatory Report, part of the Financial Times Group.

From Financial Times, Cecile Kohrs, Ryan Lynch and David Baumann reporting:
... "Jay Levine, an antitrust partner at Porter Wright, said most REMS actions have been defended on the basis that limited distribution is 'needed to comply with regulatory requirements', because the drugs are potentially so dangerous.

"But he acknowledged that the FTC is unlikely to try to use Section 5 until after McSweeny is in place, because with two Democrats and two Republican commissioners currently, the commission 'could very well be deadlocked 2-2'." ...